Friday - March 13, 2026

Autosomal Dominant Polycystic Kidney Disease Market Set for Robust Growth by 2034 Amid Advancing Therapeutics Landscape | DelveInsight

The dynamics of the autosomal dominant polycystic kidney disease market are anticipated to change in the coming years, owing to the launch of emerging therapies such as XRx-008 (Xortx Therapeutics), CYX082 (Novartis), AZD1613 (AstraZeneca), VX-407 (Vertex Pharmaceuticals), ABBV-CLS-628 (Calico Life … Continue reading

Chronic Lymphocytic Leukemia Clinical Trial Pipeline Appears Robust With 55+ Key Pharma Companies Actively Working in the Domain | DelveInsight

DelveInsight’s, “Chronic Lymphocytic Leukemia Pipeline Insight 2026” report provides comprehensive insights about 55+ companies and 60+ pipeline drugs in Chronic Lymphocytic Leukemia (CLL) pipeline landscape. It covers the Chronic Lymphocytic Leukemia pipeline drug profiles, including clinical and nonclinical stage products. … Continue reading

Cholangiocarcinoma Clinical Trial Pipeline Shows Potential with Active Contributions from 55+ Key Companies | DelveInsight

DelveInsight’s, “Cholangiocarcinoma Pipeline Insight 2026” report provides comprehensive insights about 55+ companies and 60+ pipeline drugs in Cholangiocarcinoma pipeline landscape. It covers the Cholangiocarcinoma Pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Cholangiocarcinoma pipeline therapeutics … Continue reading

Advanced Renal Cell Carcinoma Clinical Trial Pipeline Gains Momentum: 50+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s, “Advanced Renal Cell Carcinoma Pipeline Insights 2026” report provides comprehensive insights about 50+ companies and 60+ pipeline drugs in Advanced Renal Cell Carcinoma pipeline landscape. It covers the Advanced Renal Cell Carcinoma Pipeline drug profiles, including clinical and nonclinical … Continue reading

Brain Metastases Clinical Trial Pipeline Expands as 40+ Companies Driving Innovation in the Therapeutics | DelveInsight

DelveInsight’s, “Brain Metastases Pipeline Insights 2026” report provides comprehensive insights about 40+ Brain Metastases companies and 45+ pipeline drugs in Brain Metastases pipeline landscape. It covers the Brain Metastases pipeline drug profiles, including clinical and nonclinical stage products. Brain Metastases … Continue reading

Dividend Data Launches “Dividend Data for Spreadsheets,” Bringing 30+ Years of Dividend and Financial Data Directly to Excel and Google Sheets

The new spreadsheet add-in eliminates manual copy-paste research for investors and analysts, offering 16 formulas, 80,000+ supported tickers, and a permanent free tier. Dividend Data has officially announced the launch of Dividend Data for Spreadsheets, a free financial data add-in … Continue reading